A Atos
French IT corporation
Updates & Highlights
simplywall.st · 1 day ago
Atos (ENXTPA:ATO) Stock Faces Debt Strain Despite Narrower First Half Loss
GuruFocus · 2 days ago
Atos Group (AEXAF) (H1 2026) Earnings Call Highlights: Operating
GuruFocus · 2 days ago
Atossa Therapeutics (ATOS) Shows Progress but Remains Priced for High Growth Despite Losses
Recent Openings
View all 11 jobs arrow_forwardAll Jobs
Machine Learning Engineer Internship - F/H
location_on Bezons, A8, FR
Culture & Mission
Benefits & Perks
Competitive Salary
Market-rate compensation
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Generous PTO
Paid time off
401(k) Match
Retirement savings
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Atos?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
20 recentAtos (ENXTPA:ATO) Stock Faces Debt Strain Despite Narrower First Half Loss
Atos (ENXTPA:ATO) Stock Faces Debt Strain Despite Narrower First Half Loss
simplywall.st · 1 day ago
Atos Group (AEXAF) (H1 2026) Earnings Call Highlights: Operating
Atos Group (AEXAF) (H1 2026) Earnings Call Highlights: Operating
GuruFocus · 2 days ago
Atossa Therapeutics (ATOS) Shows Progress but Remains Priced for High Growth Despite Losses
Atossa Therapeutics (ATOS) Shows Progress but Remains Priced for High Growth Despite Losses
GuruFocus · 2 days ago
Atossa Therapeutics (ATOS) Explores New Uses for (Z)-Endoxifen Amid Challenging Valuation Metrics
Atossa Therapeutics (ATOS) Explores New Uses for (Z)-Endoxifen Amid Challenging Valuation Metrics
GuruFocus · 2 days ago
Atossa Therapeutics (ATOS) Focuses on Execution Amid Challenging Valuation and Mixed Guru Interest
Atossa Therapeutics (ATOS) Focuses on Execution Amid Challenging Valuation and Mixed Guru Interest
GuruFocus · 2 days ago
Atos Group 2026 Q2 - Results - Earnings Call Presentation (OTCMKTS:AEXAY) 2026-07-30
Atos Group 2026 Q2 - Results - Earnings Call Presentation (OTCMKTS:AEXAY) 2026-07-30
Seeking Alpha · 2 days ago
Atos revenue drops in H1 despite UKI momentum
Atos revenue drops in H1 despite UKI momentum
CRN UK · 3 days ago
Atos Group Reports Earnings Results for the Half Year Ended June 30, 2026
Atos Group Reports Earnings Results for the Half Year Ended June 30, 2026
marketscreener.com · 3 days ago
Atos H1 2026 slides show margin gains, but shares sink 31% on growth
Atos H1 2026 slides show margin gains, but shares sink 31% on growth
Investing.com · 3 days ago
MAIT GmbH acquired IDEAL GRP from Atos SE.
MAIT GmbH acquired IDEAL GRP from Atos SE.
marketscreener.com · 3 days ago
Earnings call transcript: Atos Group H1 2026 revenue in line as shares sink 31%
Earnings call transcript: Atos Group H1 2026 revenue in line as shares sink 31%
Investing.com · 3 days ago
Atos Group posts strong H1 2026 results, on tra...
Atos Group posts strong H1 2026 results, on tra...
Pluang · 3 days ago
Atos Group H1 Results: Operating margin jumps 43% YoY
Atos Group H1 Results: Operating margin jumps 43% YoY
scanx.trade · 3 days ago
Atos Group - H1 2026 results - Strong first-half
Atos Group - H1 2026 results - Strong first-half
GlobeNewswire · 3 days ago
Atos-CA en baisse de 8,9% au S1, objectif ajusté
Atos-CA en baisse de 8,9% au S1, objectif ajusté
TradingView · 3 days ago
Availability of Atos Group’s 2026 Half-Year Financial Report
Availability of Atos Group’s 2026 Half-Year Financial Report
GlobeNewswire · 3 days ago
Atos Group H1 Revenue At Current Scope EUR 3.30 Billion
Atos Group H1 Revenue At Current Scope EUR 3.30 Billion
TradingView · 3 days ago
Dingo Gear Atos Jute Bite Sleeve With Handle | For Dog Training, IGP, K9 & Police Work
Dingo Gear Atos Jute Bite Sleeve With Handle | For Dog Training, IGP, K9 & Police Work
umlconnector.com · 4 days ago
Atos Group Revenue Breakdown – BX:ATO
Atos Group Revenue Breakdown – BX:ATO
TradingView · 5 days ago
Atossa Therapeutics (ATOS) Unveils Promising Preclinical Breast Cancer Study Amidst Challenging Valuation
Atossa Therapeutics (ATOS) Unveils Promising Preclinical Breast Cancer Study Amidst Challenging Valuation
GuruFocus · 5 days ago